MERTK (Tyrosine-protein kinase Mer) variants and mutations
MERTK (also known as Tyrosine-protein kinase Mer) is a human protein-coding gene encoding a tyrosine-protein kinase Mer protein. It promotes engulfment of apoptotic cells and dampens inflammatory responses after activation by GAS6 or protein S, with important roles in retinal pigment epithelium and immune cells. Biallelic loss-of-function variants cause retinitis pigmentosa, while tumor cells can exploit MERTK signaling for survival and immune evasion. This analysis covers 1,417 MERTK variants and mutations. Of these, 75% have computational variant effect predictions. Disease context includes retinitis pigmentosa, Retinal dystrophy, and autosomal recessive retinitis pigmentosa. Example MERTK variants include G2V, G2W, and G2R.
Variant analysis overview
- Gene: MERTK
- Protein: Tyrosine-protein kinase Mer
- UniProt accession: Q12866
- Organism: Homo sapiens
- Variants analyzed: 1417
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 1,226 unspecified-consequence records; 96 missense variants; 70 synonymous variants; 13 frameshift variants; 4 in-frame deletions; 3 stop-gained variants; 2 splice-region variants; 1 in-frame insertions; 2 substitution
- Prediction scores: 1,063 variants have prediction scores (75% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: retinitis pigmentosa, Retinal dystrophy, autosomal recessive retinitis pigmentosa, dengue disease, hereditary disease, Leber congenital amaurosis, Posterior column ataxia - retinitis pigmentosa, retinal disorder, eye disorder, atrial fibrillation, hypertensive disorder, essential hypertension.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 5 domains; 2 binding sites; 20 post-translational modification sites.
- Structural context: 903 variants have structural context.
- PTM context: 24 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable MERTK variants
Examples include G2V, G2W, G2R, G2G, P3S, P3T, P3L, P3Q. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- G2V (p.Gly2Val), rs1424907891, ClinGen CA348232464, ClinVar RCV002000598, gnomAD rs1424907891, REVEL 0.16, MetaLR 0.19, Uncertain significance, not provided
- G2W (p.Gly2Trp), gnomAD 2-111898739-G-T, REVEL 0.32, MetaLR 0.34
- G2R (p.Gly2Arg), gnomAD 2-111898739-G-A, REVEL 0.26, MetaLR 0.24
- G2G (p.Gly2Gly), rs369484994, gnomAD 2-111898741-G-T, CADD 10.40
- P3S (p.Pro3Ser), rs952265047, TOPMed rs952265047, gnomAD rs952265047, REVEL 0.07, MetaLR 0.17, Variant assessed as somatic; moderate impact.
- P3T (p.Pro3Thr), gnomAD 2-111898742-C-A, REVEL 0.09, MetaLR 0.17
- P3L (p.Pro3Leu), gnomAD 2-111898743-C-T, REVEL 0.12, MetaLR 0.15
- P3Q (p.Pro3Gln), gnomAD 2-111898743-C-A, REVEL 0.16, MetaLR 0.15
- P3P (p.Pro3Pro), rs1319516641, gnomAD 2-111898744-G-A, CADD 7.36
- A4G (p.Ala4Gly), Ensembl rs1297079705
- A4S (p.Ala4Ser), gnomAD rs1326403828, REVEL 0.09, AlphaMissense 0.16
- A4T (p.Ala4Thr), rs1326403828, ClinGen CA348232491, ClinVar RCV003020755, AlphaMissense 0.16, MetaLR 0.17, Uncertain significance, not provided
- A4V (p.Ala4Val), Ensembl rs1297079705, REVEL 0.11, MetaLR 0.18
- A4P (p.Ala4Pro), rs1402909136, gnomAD 2-111898743-CG-C, CADD 16.70
- A4A (p.Ala4Ala), gnomAD 2-111898747-C-A, CADD 5.62
- P5A (p.Pro5Ala), gnomAD rs1286101631
- P5L (p.Pro5Leu), rs766821604, ClinGen CA1830942, ClinVar RCV001374059, ExAC rs766821604, REVEL 0.07, AlphaMissense 0.17, Uncertain significance, not provided
- P5R (p.Pro5Arg), rs766821604, ClinGen CA348232511, ClinVar RCV003030645, AlphaMissense 0.17, MetaLR 0.13, Uncertain significance, not provided
- P5S (p.Pro5Ser), gnomAD rs1286101631, REVEL 0.07, MetaLR 0.17
- P5P (p.Pro5Pro), rs1245540834, gnomAD 2-111898750-G-A, CADD 12.00
- L6M (p.Leu6Met), TOPMed rs1683973487
- L6P (p.Leu6Pro), gnomAD 2-111898752-T-C, REVEL 0.16, MetaLR 0.22
- L6L (p.Leu6Leu), rs1290699644, gnomAD 2-111898753-G-A, CADD 11.30
- P7T (p.Pro7Thr), gnomAD rs1683973586, REVEL 0.10, MetaLR 0.16
- P7S (p.Pro7Ser), gnomAD 2-111898754-C-T, REVEL 0.11, MetaLR 0.16
- P7Q (p.Pro7Gln), gnomAD 2-111898755-C-A, REVEL 0.09, MetaLR 0.14
- P7L (p.Pro7Leu), gnomAD 2-111898755-C-T, REVEL 0.06, MetaLR 0.12
- P7P (p.Pro7Pro), rs752112582, gnomAD 2-111898756-G-T, CADD 11.70
- L8P (p.Leu8Pro), Ensembl rs867971321, REVEL 0.15, MetaLR 0.21
- L8V (p.Leu8Val), TOPMed rs1683973817
- L8M (p.Leu8Met), gnomAD 2-111898757-C-A, REVEL 0.08, MetaLR 0.20
- L8L (p.Leu8Leu), gnomAD 2-111898759-G-T, CADD 7.27
- L9M (p.Leu9Met), Ensembl rs1558763288
- L9P (p.Leu9Pro), gnomAD 2-111898761-T-C, REVEL 0.39, MetaLR 0.19
- L9R (p.Leu9Arg), gnomAD 2-111898761-T-G, REVEL 0.35, MetaLR 0.19
- L9L (p.Leu9Leu), rs1683973924, gnomAD 2-111898762-G-A, CADD 12.00
- L10del (p.Leu10del), rs766822912, gnomAD 2-111898755-CGCT-, CADD 15.40
- L10M (p.Leu10Met), gnomAD 2-111898763-C-A, REVEL 0.10, MetaLR 0.20
- L10L (p.Leu10Leu), gnomAD 2-111898763-C-T, CADD 13.30
- L10P (p.Leu10Pro), gnomAD 2-111898764-T-C, REVEL 0.21, MetaLR 0.20
- G11A (p.Gly11Ala), Ensembl rs1573554218, REVEL 0.12, MetaLR 0.19
- G11D (p.Gly11Asp), Ensembl rs1573554218
- G11C (p.Gly11Cys), gnomAD 2-111898766-G-T, REVEL 0.18, MetaLR 0.25
- G11S (p.Gly11Ser), gnomAD 2-111898766-G-A, REVEL 0.10, MetaLR 0.17
- G11V (p.Gly11Val), gnomAD 2-111898767-G-T, REVEL 0.13, MetaLR 0.19
- G11G (p.Gly11Gly), gnomAD 2-111898768-C-A, CADD 8.06
- L12F (p.Leu12Phe), rs755593299, ClinGen CA1830945, ClinVar RCV001939105, ExAC rs755593299, REVEL 0.14, MetaLR 0.17, Uncertain significance, not provided
- L12V (p.Leu12Val), gnomAD 2-111898769-C-G, REVEL 0.11, MetaLR 0.18
- L12I (p.Leu12Ile), gnomAD 2-111898769-C-A, REVEL 0.07, MetaLR 0.18
- L12P (p.Leu12Pro), gnomAD 2-111898770-T-C, REVEL 0.53, MetaLR 0.23
- L12L (p.Leu12Leu), gnomAD 2-111898771-C-A, CADD 8.21
- F13Y (p.Phe13Tyr), Ensembl rs1683974167
- F13L (p.Phe13Leu), gnomAD 2-111898774-C-A, REVEL 0.07, MetaLR 0.09
- F13F (p.Phe13Phe), gnomAD 2-111898774-C-T, CADD 8.97
- L14F (p.Leu14Phe), ExAC rs777333807, TOPMed rs777333807, gnomAD rs777333807, REVEL 0.14, MetaLR 0.20
- L14I (p.Leu14Ile), gnomAD 2-111898775-C-A, REVEL 0.07, MetaLR 0.20
- L14V (p.Leu14Val), gnomAD 2-111898775-C-G, REVEL 0.09, MetaLR 0.20
- L14L (p.Leu14Leu), gnomAD 2-111898777-C-A, CADD 5.82
- P15H (p.Pro15His), Ensembl rs1573554231, REVEL 0.08, MetaLR 0.15
- P15L (p.Pro15Leu), Ensembl rs1573554231, REVEL 0.12, MetaLR 0.16, Uncertain significance, Inborn genetic diseases
- P15S (p.Pro15Ser), gnomAD 2-111898778-C-T, REVEL 0.08, MetaLR 0.15
- P15P (p.Pro15Pro), rs748928622, gnomAD 2-111898780-C-T, CADD 3.88
- A16T (p.Ala16Thr), cosmic curated COSV10882, ExAC rs756874549, gnomAD rs756874549, REVEL 0.10, MetaLR 0.21
- A16R (p.Ala16Arg), gnomAD 2-111898780-CG-C, CADD 23.50
- A16S (p.Ala16Ser), gnomAD 2-111898781-G-T, REVEL 0.10, MetaLR 0.21
- A16V (p.Ala16Val), gnomAD 2-111898782-C-T, REVEL 0.07, MetaLR 0.19
- A16E (p.Ala16Glu), gnomAD 2-111898782-C-A, REVEL 0.25, MetaLR 0.21
- A16A (p.Ala16Ala), gnomAD 2-111898783-G-T, CADD 5.08
- L17F (p.Leu17Phe), ExAC rs778704547, gnomAD rs778704547, REVEL 0.19, MetaLR 0.23
- L17I (p.Leu17Ile), gnomAD 2-111898784-C-A, REVEL 0.07, MetaLR 0.18
- L17V (p.Leu17Val), gnomAD 2-111898784-C-G, REVEL 0.12, MetaLR 0.15
- L17L (p.Leu17Leu), gnomAD 2-111898786-C-A, CADD 4.98
- W18C (p.Trp18Cys), ExAC rs745681896, gnomAD rs745681896, REVEL 0.24, MetaLR 0.21
- W18R (p.Trp18Arg), gnomAD rs1683974540, REVEL 0.14, MetaLR 0.20
- W18* (p.Trp18Ter), gnomAD 2-111898788-G-A, CADD 35.00
- W18L (p.Trp18Leu), gnomAD 2-111898788-G-T, REVEL 0.17, MetaLR 0.19
- R19G (p.Arg19Gly), Ensembl rs1683974613, REVEL 0.05, MetaLR 0.15
- R19H (p.Arg19His), TOPMed rs1017599113, gnomAD rs1017599113, REVEL 0.12, MetaLR 0.12, Uncertain significance
- R19L (p.Arg19Leu), rs1017599113, ClinGen CA53582099, ClinVar RCV001913799, ClinVar RCV004756315, REVEL 0.06, MetaLR 0.16, Uncertain significance, not provided
- R19C (p.Arg19Cys), gnomAD 2-111898790-C-T, REVEL 0.17, MetaLR 0.10
- R19S (p.Arg19Ser), gnomAD 2-111898790-C-A, REVEL 0.06, MetaLR 0.11
- R19R (p.Arg19Arg), gnomAD 2-111898792-T-C, CADD 3.14
- R20G (p.Arg20Gly), Ensembl rs2104652809
- R20S (p.Arg20Ser), rs35898499, ClinGen CA148491, cosmic curated COSV54924, ClinVar RCV000081391, REVEL 0.08, MetaLR 0.03, Conflicting interpretations, not specified; not provided; Retinitis pigmentosa
- R20T (p.Arg20Thr), rs552509122, ClinGen CA1830951, ClinVar RCV001974722, 1000Genomes rs552509122, REVEL 0.38, MetaLR 0.15, Uncertain significance, not provided
- R20I (p.Arg20Ile), gnomAD 2-111898794-G-T, REVEL 0.11, MetaLR 0.15
- A21S (p.Ala21Ser), gnomAD 2-111898796-G-T, REVEL 0.20, MetaLR 0.22
- A21A (p.Ala21Ala), gnomAD 2-111929121-T-C, CADD 2.09
- I22V (p.Ile22Val), gnomAD 2-111929122-A-G, REVEL 0.10, MetaLR 0.10
- I22N (p.Ile22Asn), gnomAD 2-111929123-T-A, REVEL 0.09, MetaLR 0.21
- I22I (p.Ile22Ile), gnomAD 2-111929124-C-T, CADD 0.83
- T23I (p.Thr23Ile), ExAC rs781350196, TOPMed rs781350196, gnomAD rs781350196, REVEL 0.10, MetaLR 0.20
- T23N (p.Thr23Asn), ExAC rs781350196, TOPMed rs781350196, gnomAD rs781350196, REVEL 0.08, MetaLR 0.20
- E24E (p.Glu24Glu), gnomAD 2-111929130-G-A, CADD 0.60
- A25T (p.Ala25Thr), Ensembl rs1047217052
- R26K (p.Arg26Lys), gnomAD rs1374883963
- E27* (p.Glu27Ter), TOPMed rs1223798126, CADD 36.00
- E27G (p.Glu27Gly), TOPMed rs1480349594, gnomAD rs1480349594, REVEL 0.12, MetaLR 0.27
- E27K (p.Glu27Lys), NCI-TCGA Cosmic COSV5492, cosmic curated COSV54925, Variant assessed as somatic; moderate impact.
- E28K (p.Glu28Lys), ExAC rs748203904, TOPMed rs748203904, gnomAD rs748203904, REVEL 0.10, MetaLR 0.27
- A29G (p.Ala29Gly), rs1206954845, ClinGen CA348225895, ClinVar RCV001983923, ClinVar RCV002592643, REVEL 0.14, MetaLR 0.17, Uncertain significance, not provided; Inborn genetic diseases
- A29S (p.Ala29Ser), gnomAD 2-111929143-G-T, REVEL 0.05, MetaLR 0.18
- K30N (p.Lys30Asn), rs1308272767, ClinGen CA348225903, ClinVar RCV002816116, TOPMed rs1308272767, REVEL 0.08, MetaLR 0.19, Uncertain significance, not provided
- P31L (p.Pro31Leu), rs1167524389, ClinGen CA348225909, ClinVar RCV002037151, TOPMed rs1167524389, REVEL 0.10, MetaLR 0.20, Uncertain significance, not provided
- P31T (p.Pro31Thr), TOPMed rs928953402
- Y32N (p.Tyr32Asn), ExAC rs769970062, gnomAD rs769970062, REVEL 0.10, MetaLR 0.10
- P33L (p.Pro33Leu), rs144751432, ClinGen CA1830976, cosmic curated COSV99775, ClinVar RCV001059261, REVEL 0.08, MetaLR 0.08, Conflicting interpretations, not provided; Retinitis pigmentosa
- P33Q (p.Pro33Gln), ESP rs144751432, ExAC rs144751432, TOPMed rs144751432, gnomAD rs144751432, REVEL 0.12, MetaLR 0.12, Likely benign
- P33S (p.Pro33Ser), ExAC rs773279871, TOPMed rs773279871, gnomAD rs773279871, REVEL 0.09, MetaLR 0.16, Uncertain significance, Inborn genetic diseases
- P33T (p.Pro33Thr), ExAC rs773279871, TOPMed rs773279871, gnomAD rs773279871
- P33R (p.Pro33Arg), rs1407749594, gnomAD 2-111929153-AC-A, CADD 15.70
- P33A (p.Pro33Ala), gnomAD 2-111929155-C-G, REVEL 0.06, MetaLR 0.16
- P33P (p.Pro33Pro), rs771189892, gnomAD 2-111929157-G-A, CADD 0.85
- L34H (p.Leu34His), rs1232588665, gnomAD 2-111929158-CT-C, CADD 8.55
- L34L (p.Leu34Leu), gnomAD 2-111929158-C-T, CADD 1.34
- L34P (p.Leu34Pro), gnomAD 2-111929159-T-C, REVEL 0.17, MetaLR 0.14
- F35C (p.Phe35Cys), Ensembl rs1684622007
- F35F (p.Phe35Phe), rs759971068, gnomAD 2-111929163-C-T, CADD 0.45
- P36L (p.Pro36Leu), rs150870104, ClinGen CA1830981, ClinVar RCV000955958, 1000Genomes rs150870104, REVEL 0.12, MetaLR 0.16, Likely benign, not provided
- P36S (p.Pro36Ser), Ensembl rs1684622100
- P36R (p.Pro36Arg), rs759734206, gnomAD 2-111929162-TC-T, CADD 6.91
- P36P (p.Pro36Pro), rs367707279, gnomAD 2-111929166-G-A, CADD 0.26
- G37E (p.Gly37Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G37V (p.Gly37Val), gnomAD rs1250331085
- G37A (p.Gly37Ala), gnomAD 2-111929168-G-C, REVEL 0.06, MetaLR 0.26
- P38S (p.Pro38Ser), gnomAD 2-111929170-C-T, REVEL 0.05, MetaLR 0.21
- P38R (p.Pro38Arg), gnomAD 2-111929171-C-G, REVEL 0.18, MetaLR 0.28
- F39F (p.Phe39Phe), gnomAD 2-111929175-T-C, CADD 1.63
- P40A (p.Pro40Ala), TOPMed rs1684622296
- P40L (p.Pro40Leu), rs1684622333, ClinGen CA348225964, cosmic curated COSV54925, ClinVar RCV001244024, REVEL 0.24, MetaLR 0.46, Uncertain significance, not provided
- G41E (p.Gly41Glu), gnomAD 2-111929180-G-A, REVEL 0.07, MetaLR 0.21
- G41G (p.Gly41Gly), rs144162028, gnomAD 2-111929181-G-A, CADD 2.59
- S42N (p.Ser42Asn), NCI-TCGA Cosmic COSV5493, cosmic curated COSV54935, REVEL 0.14, MetaLR 0.20, Variant assessed as somatic; moderate impact.
- S42S (p.Ser42Ser), rs1292975350, gnomAD 2-111929184-C-T, CADD 2.02
- L43L (p.Leu43Leu), rs1684622470, gnomAD 2-111929187-G-A, CADD 1.20
- Q44R (p.Gln44Arg), ExAC rs764842052, gnomAD rs764842052, REVEL 0.09, MetaLR 0.18
- Q44Q (p.Gln44Gln), rs1479452583, gnomAD 2-111929190-A-G, CADD 2.31
- T45I (p.Thr45Ile), TOPMed rs1684622606, gnomAD rs1684622606, REVEL 0.07, MetaLR 0.16
- T45T (p.Thr45Thr), gnomAD 2-111929193-T-G, CADD 2.33
- D46E (p.Asp46Glu), rs527694612, ClinGen CA1830985, ClinVar RCV000305032, ClinVar RCV001410430, REVEL 0.18, MetaLR 0.22, Conflicting interpretations, not provided; Retinitis pigmentosa
- D46D (p.Asp46Asp), rs527694612, gnomAD 2-111929196-C-T, CADD 1.32
- H47P (p.His47Pro), Ensembl rs1558775220, REVEL 0.19, MetaLR 0.18
- H47R (p.His47Arg), Ensembl rs1558775220, REVEL 0.15, MetaLR 0.16
- T48P (p.Thr48Pro), Ensembl rs1684622745, REVEL 0.13, MetaLR 0.20
- T48I (p.Thr48Ile), gnomAD 2-111929201-C-T, REVEL 0.10, MetaLR 0.17
- T48T (p.Thr48Thr), rs547764575, gnomAD 2-111929202-A-G, CADD 0.30
- P49L (p.Pro49Leu), rs567766808, ClinGen CA1830987, cosmic curated COSV54928, ClinVar RCV001211541, REVEL 0.20, MetaLR 0.23, Uncertain significance, Inborn genetic diseases; not provided
- P49Q (p.Pro49Gln), NCI-TCGA Cosmic COSV5492, cosmic curated COSV54928, Variant assessed as somatic; moderate impact.
- P49P (p.Pro49Pro), rs751401674, gnomAD 2-111929205-G-A, CADD 0.53
- L50L (p.Leu50Leu), gnomAD 2-111929208-G-C, CADD 0.16
- L51* (p.Leu51Ter), NCI-TCGA Cosmic COSV5493, cosmic curated COSV54930, Variant assessed as somatic; high impact.
- L51L (p.Leu51Leu), gnomAD 2-111929209-T-C, CADD 1.79
- L51S (p.Leu51Ser), gnomAD 2-111929210-T-C, REVEL 0.15, MetaLR 0.19
- S52C (p.Ser52Cys), gnomAD rs1426789116, REVEL 0.23, MetaLR 0.22
- S52F (p.Ser52Phe), cosmic curated COSV10733, gnomAD rs1426789116, REVEL 0.12, MetaLR 0.19
- S52P (p.Ser52Pro), Ensembl rs1684622948, REVEL 0.17, MetaLR 0.20
- S52T (p.Ser52Thr), gnomAD 2-111929212-T-A, REVEL 0.08, MetaLR 0.22
- L53F (p.Leu53Phe), gnomAD 2-111929212-TC-T, CADD 17.60
- L53R (p.Leu53Arg), gnomAD 2-111929216-T-G, REVEL 0.15, MetaLR 0.17
- H55D (p.His55Asp), ExAC rs754922274, gnomAD rs754922274, Uncertain significance
- H55N (p.His55Asn), rs754922274, ClinGen CA348226053, ClinVar RCV001356697, ExAC rs754922274, AlphaMissense 0.08, MetaLR 0.20, Uncertain significance, not provided
- H55Q (p.His55Gln), ExAC rs781297101, TOPMed rs781297101, gnomAD rs781297101, REVEL 0.21, MetaLR 0.21, Likely benign
- H55Y (p.His55Tyr), rs754922274, NCI-TCGA Cosmic COSV9977, cosmic curated COSV99774, ExAC rs754922274, REVEL 0.12, AlphaMissense 0.08, Uncertain significance
- H55H (p.His55His), rs781297101, gnomAD 2-111929223-C-T, CADD 0.76
- A56T (p.Ala56Thr), rs868686893, ClinGen CA53560980, cosmic curated COSV54935, ClinVar RCV000997191, REVEL 0.12, MetaLR 0.09, Uncertain significance, not provided
- S57N (p.Ser57Asn), rs1051108169, ClinGen CA53560988, ClinVar RCV001990459, TOPMed rs1051108169, REVEL 0.07, MetaLR 0.21, Uncertain significance, not provided
- S57T (p.Ser57Thr), TOPMed rs1051108169, gnomAD rs1051108169, Uncertain significance
- S57I (p.Ser57Ile), gnomAD 2-111929228-G-T, REVEL 0.05, MetaLR 0.22
- G58E (p.Gly58Glu), gnomAD rs1291686201, REVEL 0.40, MetaLR 0.20
- G58R (p.Gly58Arg), gnomAD rs1423887739, REVEL 0.12, MetaLR 0.18
- G58S (p.Gly58Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- G58V (p.Gly58Val), gnomAD rs1291686201, REVEL 0.22, MetaLR 0.24
- G58G (p.Gly58Gly), rs768500497, gnomAD 2-111929232-G-A, CADD 5.71
- Y59H (p.Tyr59His), ExAC rs748161559, REVEL 0.16, MetaLR 0.16
- Y59S (p.Tyr59Ser), Ensembl rs1573577855
- p.Tyr59 Gln60insHis, rs767659479, gnomAD 2-111929233-T-TAC, CADD 12.30
- Y59C (p.Tyr59Cys), gnomAD 2-111929234-A-G, REVEL 0.13, MetaLR 0.20
- Y59Y (p.Tyr59Tyr), gnomAD 2-111929235-C-T, CADD 8.64
- Q60K (p.Gln60Lys), rs376885459, cosmic curated COSV99775, ESP rs376885459, TOPMed rs376885459, AlphaMissense 0.08, MetaLR 0.19, Variant assessed as somatic; moderate impact.
- P61T (p.Pro61Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
Public MERTK analysis runs
- MERTK analysis run — MERTK (1,417 variants) — completed 2026-08-20